Refine by
Sensor System Articles & Analysis
44 news found
Vitalograph has researched, developed, and manufactured the VitaloJAK® cough monitoring system, which records and digitises cough sounds. This is a unique and innovative solution that has enabled the impact of chronic cough therapies to be objectively assessed. ...
Alertgy has been granted a patent for their innovative and groundbreaking radio frequency sensor technology. The awarded patent, Apparatus for in vivo dielectric spectroscopy (US20200217809A1), focuses on sensor technology that is 100% non-invasive and continuously monitors blood glucose in a way that does not involve blood oxidase, but rather dielectric ...
ByAlertgy
This generation 2 Alertgy wristband will be smaller and more form fitting for the user and will include a plethora of additional sensors and functionalities, including sensors for measuring heart rate and blood oxygen. ...
ByAlertgy
Alertgy has partnered with Florida Atlantic University’s (FAU) Immunology and Virology Department to execute a collaborative study on the diagnostic capabilities of Alertgy’s newly patented dielectric sensor technology and its possibilities to detect the COVID-19 virus. ...
ByAlertgy
Breakthrough pulse oximetry (SpO2 ) optical sensor solution offers medical-grade accuracy of oxygen level measurement across skin tones and while in motion Patented SpO2 sensor chipset, integrated processing and reference design capability to power the next generation of medical and consumer wearable devices BioIntelliSense, a continuous health monitoring and clinical intelligence company, ...
The device can transmit the data on cardiac hemodynamic parameters to clinicians through cellular networks, and uses AI-based algorithms to identify a variety of hemodynamic biomarkers to aid in early identification and diagnosis. The system also incorporates a digital dashboard that lets healthcare staff to easily view trends in a patient’s data over time. ...
Senstech sensors can be found in a variety of applications in the medical field, such as infusion or insulin pumps, in cardiotocography or in devices for eye surgery. Other important areas of application are textile machinery, mechanical engineering, the watch industry, industrial pressure measurement technology, and applications for cars. In addition to OEM sensor solutions the company also ...
Sensor advancements are driving innovation in both wearable devices and surgical devices. ...
Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), today announced positive data from the SIRONA 2 clinical trial evaluating safety and efficacy of its Cordella™ Pulmonary Artery Pressure Sensor System (Cordella Sensor) in New York Heart Association (NYHA) class III ...
Sydney medical device company Baymatob has completed a placement of $4.215 million, with proceeds used to continue in-human clinical trials for its AI-guided labour monitoring device, Oli. Cornerstoned by Australian Unity’s Future of Healthcare Fund, the placement was strongly supported by Australian institutional and high net worth investors, securing long-term capital partners to support ...
Recent Highlights & Accomplishments: Received approval from the Food and Drug Administration (FDA) for the Eversense® E3 CGM System, offering patients: Fully implantable third generation sensor, with proprietary sacrificial boronic acid (SBA) technology to enhance sensor longevity, demonstrating a mean absolute relative difference ...
The update broadens the stimulation pulse width parameter to the widest range currently available in implantable SCS and PNS systems—up to 2,000 microseconds. The Nalu Neurostimulation System is optimized to utilize this energy-hungry parameter due to its external, wearable battery. ...
“The next generation Eversense E3 System delivers on both. Patients will appreciate the excellent accuracy of the system and the ability of the sensor to last 6 months. This is another step forward for patients who desire to manage their diabetes with all the advantages of the Eversense CGM with the fully implantable ...
“Understanding changes in PA pressure data is key to properly implementing guideline directed medical therapy and keeping these patients out of the hospital. The Cordella HF System and Sensor offers the next gen technology in PA pressure sensing and will play a critical part in how heart failure patients are managed moving ...
Food and Drug Administration (FDA) 510(k) clearance of the TearCare® System for the treatment of meibomian gland dysfunction (MGD), the leading cause of dry eye disease (DED). ...
In a community-based study of the accuracy of PD diagnosis, essential tremor (ET), the most common movement disorder, accounted for 48% of the misdiagnoses.2 The widespread lack of tremor measurement equipment in the clinic with the ability to detect very subtle tremors is a significant part of the cause for not being able to differentiate between PD and ET.3 4 5 6 The NeuroMotor Pen™ is ...
Jacksonville, FL– December 16, 2021 -- RCSM, a leader in respiratory and sleep medicine in Florida, and Spire Health, the leading digital healthcare company for respiratory remote patient monitoring (RPM), today announced a partnership to provide a remote monitoring service to respiratory patients in the Jacksonville area. The new service helps RCSM pulmonologists detect changes in clinical ...
The overall project is carried out by the 6 partners in the respective subprojects. The subproject "Total device system for cartridge readout" is mainly carried out by BYTEC. The aim is the realization of a device platform for the combination of all single modules for the readout of sample material for the analysis of food for toxins. The device platform serves to accommodate ...
A novel study published in the (TBD) issue of Sensors, the leading international,?peer-reviewed, open access journal on the science and technology of sensors – entitled Test-Retest Reliability of PODOSmart® Gait Analysis Insoles – concluded that Digitsole’s ...
Manus Neurodynamica Limited (“Manus”), which develops and markets products and technologies for neuromotor assessment, has received £600,000 grant funding from Innovate UK, to optimise and validate the NeuroMotor PenTM (NMP) for screening of dementias and cognitive impairment, over a two-year project. Only around 68% of over 65s, estimated to have dementia have been diagnosed. ...